Evidence map›Paper›PMID 36715723›Full record

ArticleArchives of dermatological research2023

Development of the lichen planus quality of life questionnaire (LPQoL) informed by expert clinician input and patient feedback: a retrospective survey study.

Fangyi Xie, Colleen M Morken, Nan Zhang, Mark R Pittelkow, Julio C Sartori Valinotti, Nneka I Comfere, Alexander Meves, Dennis H Murphree, Aaron R Mangold, Julia S Lehman and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Lichen Planus: What is New in Diagnosis and Treatment?American journal of clinical dermatology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fangyi XieDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-5524-2750
Colleen M MorkenDepartment of Dermatology, Mayo Clinic Arizona, 5777 E. Mayo Blvd., Phoenix, AZ, 85054, USA.ORCID http://orcid.org/0000-0001-8243-1960
Nan ZhangDepartment of Quantitative Health Sciences, Mayo Clinic Arizona, 5777 E. Mayo Blvd, Phoenix, AZ, 85054, USA.ORCID http://orcid.org/0000-0002-0985-4227
Mark R PittelkowDepartment of Dermatology, Mayo Clinic Arizona, 5777 E. Mayo Blvd., Phoenix, AZ, 85054, USA.ORCID http://orcid.org/0000-0001-7913-0294
Julio C Sartori ValinottiDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-8965-5403
Nneka I ComfereDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-8001-2639
Alexander MevesDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-7462-8288
Dennis H MurphreeDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-7800-455X
Aaron R MangoldDepartment of Dermatology, Mayo Clinic Arizona, 5777 E. Mayo Blvd., Phoenix, AZ, 85054, USA.ORCID http://orcid.org/0000-0001-6873-1705
Julia S LehmanDepartment of Dermatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. lehman.julia@mayo.edu.ORCID http://orcid.org/0000-0002-7389-3853
Mayo Clinic Lichen Planus Consortium

Funding

British Association of Dermatologists Geoffrey Dowling Fellowship
6 · The paper itself

Abstract

Lichen planus (LP) can affect multiple body sites including skin, mucosae, scalp and nails, causing considerable impact on patients' quality of life. Currently, there are no LP patient-reported outcome measures (PROMs) that address all body sites potentially affected by LP. We developed a LP Quality of Life Questionnaire (LPQoL), informed by an expert consortium and patient survey study, to address this gap. The study was approved by our institution's Institutional Review Board. First, a 22-item LPQoL was designed with input from LP experts at our institution. The tool was then optimized by garnering input from patients recently diagnosed with LP, who were asked to complete the LPQoL, as well as the Dermatology Life Quality Index (DLQI) and a feedback form about the LPQoL. Fifty-eight of 150 patients (39% response rate) returned the questionnaire. Mean DLQI score was 4.9 ± 5.6 SD (range 0-25) and mean LPQoL score was 13.6 ± 10.4 SD (range 0-54). LPQoL score was positively correlated with DLQI score (r = 0.79; p < 0.001). Forty-nine out of 56 (88%) and 6/56 (11%) rated the LPQoL as 'very easy' or 'fairly easy' to complete, respectively. Based on participants' feedback, we increased the recall period from one week to one month and added questions on esophageal involvement. With iterative input from LP experts and patients, we developed a LPQoL to address the gap in a multi-site PROM specific to LP. This is a pilot study and there is ongoing validation studies; therefore, this measure should not be used in clinical practice or research until validated.

Indexed as

Lichen PlanusQuality of LifeFeedbackHumansPilot ProjectsRetrospective StudiesSurveys and QuestionnairesLichen planopilarisLichen planusMucosal diseasePatient-reported outcome measuresQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.